期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 22, 页码 15327-15343出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c01299
关键词
-
资金
- Welch Foundation
- NIH
- [I-1612]
- [R01CA216863 RM1GM142002]
- [R35CA197442]
- [R50CA211119]
In this study, a novel class of quinoxaline amides was found to exhibit potent inhibition of 15-PGDH, resulting in elevated levels of PGE2 and promoting tissue repair and regeneration. These compounds also demonstrated good oral bioavailability and protective activity in mouse models of ulcerative colitis and recovery from bone marrow transplantation.
15-Prostaglandin dehydrogenase (15-PGDH) regulates the concentration of prostaglandin E2 in vivo. Inhibitors of 15-PGDH elevate PGE2 levels and promote tissue repair and regeneration. Here, we describe a novel class of quinoxaline amides that show potent inhibition of 15-PGDH, good oral bioavailability, and protective activity in mouse models of ulcerative colitis and recovery from bone marrow transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据